EUVIMEDEUVIMED entdecken
Multizentrische Studie

Appropriateness of implantable cardioverter-defibrillator device implants in the United States

Omair K Yousuf, Kevin Kennedy, Andrea Russo, Paul Varosy, Bruce D Lindsay, Benjamin Steinberg, Brett D Atwater, Hugh Calkins, John A Spertus

Heart Rhythm · 2024

DOI: 10.1016/j.hrthm.2023.12.005 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Heart Rhythm, 2024. Verfasst von Omair K Yousuf und 8 weiteren Autor:innen. Beteiligte Einrichtung: Saint Luke's Mid America Heart Institute, Kansas City, Missouri; Carient Heart & Vascular, Manassas, Virginia; Inova Heart and Vascular Institute, Fa…. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Pacemaker, Artificial, Cardiac Resynchronization Therapy, Heart Failure. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Patient-Centered Outcomes Research Institute, National Heart, Lung, and Blood Institute, Boston Scientific Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The appropriate use criteria (AUCs) are a diverse group of indications aimed to better evaluate the benefits of implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy. OBJECTIVE: The purpose of this study was to quantify the proportion of ICD and cardiac resynchronization therapy with defibrillator (CRT-D) implants as appropriate, may be appropriate (MA), or rarely appropriate (RA) on the basis of the AUC guidelines. METHODS: This is a multicenter retrospective study of patients within the National Cardiovascular Data Registry undergoing ICD implantation between April 2018 and March 2019 at >1500 US hospitals. The appropriateness of ICD implants was adjudicated using the AUC. RESULTS: Of 309,318 ICDs, 241,438 were primary prevention implants (78.1%) and 67,880 secondary prevention implants (21.9%); 243,532 (79%) were mappable to the AUC. For primary prevention, 185,431 ICDs (96.4%) were appropriate, 5660 (2.9%) MA, and 1205 (0.6%) RA. For secondary prevention, 47,498 ICDs (92.7%) were appropriate, 2581 (5%) MA, and 1157 (2.3%) RA. A significant number of RA devices were implanted in patients with New York Heart Association class IV heart failure who were ineligible for advanced therapies (53.9%) and those with myocardial infarction within 40 days (18.1%). The appropriateness of the pacing lead was more variable, with 48,470 dual-chamber ICD implants (62%) being classified as appropriate, 29,209 (37.4%) MA, and 448 (0.6%) RA. Among CRT-D implants, 63,848 (82.2%) were appropriate, 9900 (12.7%) MA, and 3940 (5.1%) RA for left ventricular pacing. A total of 99,754 implants were deemed appropriate but excluded from Centers for Medicare & Medicaid Services National Coverage Determination. More than 92% of hospitals had an RA implant rate of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantablePacemaker, ArtificialCardiac Resynchronization TherapyHeart FailureHumansAgedUnited StatesRetrospective StudiesMedicareRegistries

Stichwörter der Autor:innen

American College of CardiologyAppropriatenessCardiac resynchronization therapyImplantable cardioverter-defibrillatorNational Cardiovascular Data RegistryOutcomesPrimary preventionSecondary preventionSudden cardiac death

Autor:innen und Institutionen

  • Saint Luke's Mid America Heart Institute, Kansas City, Missouri; Carient Heart & Vascular, Manassas, Virginia; Inova Heart and Vascular Institute, Fairfax, Virginia; University of Virginia Health, Manassas, Virginia. El…
  • Saint Luke's Mid America Heart Institute, Kansas City, Missouri.
  • Cooper Health, Voorhees, New Jersey.
  • University of Colorado, Denver, Colorado.
  • Cleveland Clinic, Cleveland, Ohio.
  • University of Utah, Salt Lake City, Utah.

Förderung

  • Patient-Centered Outcomes Research Institute
  • National Heart, Lung, and Blood Institute
  • Boston Scientific Corporation
  • American Heart Association
  • National Institutes of Health
  • Sanofi

Zitieren

APA

Yousuf, O. K., Kennedy, K., Russo, A., Varosy, P., Lindsay, B. D., Steinberg, B., Atwater, B. D., Calkins, H., & Spertus, J. A. (2024). Appropriateness of implantable cardioverter-defibrillator device implants in the United States. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2023.12.005

Vancouver

Yousuf OK, Kennedy K, Russo A, Varosy P, Lindsay BD, Steinberg B, et al. Appropriateness of implantable cardioverter-defibrillator device implants in the United States. Heart Rhythm. 2024. doi:10.1016/j.hrthm.2023.12.005

BibTeX
@article{Yousuf2024,
  author = {Yousuf, Omair K and Kennedy, Kevin and Russo, Andrea and Varosy, Paul and Lindsay, Bruce D and Steinberg, Benjamin and Atwater, Brett D and Calkins, Hugh and Spertus, John A},
  title = {Appropriateness of implantable cardioverter-defibrillator device implants in the United States},
  journal = {Heart Rhythm},
  year = {2024},
  doi = {10.1016/j.hrthm.2023.12.005}
}
Kostenlos starten →